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A B S T R A C T
Background: Brain injury in preterm infants represents a substantial clinical problem associated with develop-
ment of motor impairment, cognitive deﬁcits and psychiatric problems. According to clinical studies, magnesium
sulphate (MgSO4) given to women in preterm labor reduces the risk of cerebral palsy in the oﬀspring but the
mechanisms behind its neuroprotective eﬀects are still unclear. Our aim was to explore whether MgSO4 induces
tolerance (preconditioning) in the preterm rodent brain. For this purpose we established a model of perinatal
hypoxia-ischemia (HI) in postnatal day 4 rats and also applied a recently developed postnatal day 5 mouse model
of perinatal brain injury.
Methods: Postnatal day 4 Wistar rats were exposed to unilateral carotid artery ligation followed by 60, 70 or
80min of hypoxia (8% O2). On postnatal day 11, brains were collected and macroscopically visible damage as
well as white and grey matter injury was examined using immunohistochemical staining. Once the model had
been established, a possible preconditioning protection induced by a bolus MgSO4 injection prior to 80min HI
was examined 7 days after the insult. Next, a MgSO4 bolus was injected in C57Bl6 mice on PND 4 followed by
exposure to unilateral carotid artery ligation and hypoxia, (10% O2) for 70min on PND 5. Brains were collected
7 days after the insult and examined with immunohistochemistry for grey and white matter injury.
Results: In rats, a 60min period of hypoxia resulted in very few animals with brain injury and although 70min of
hypoxia resulted in a higher percentage of injured animals, the brains were marginally damaged. An 80min
exposure of hypoxia caused cortical tissue damage combined with hippocampal atrophy and neuronal loss in the
C3 hippocampal layer.
In the rat model, MgSO4 (1.1 mg/g administered i.p. 24 h prior to the induction of HI, resulting in a transient
serum Mg2+ concentration elevation to 4.1 ± 0.2mmol/l at 3 h post i.p. injection) reduced brain injury by 74%
in grey matter and 64% in white matter.
In the mouse model, MgSO4 (0.92mg/g) i.p. injection given 24 h prior to the HI insult resulted in a Mg2+
serum concentration increase reaching 2.7 ± 0.3mmol/l at 3 h post injection, which conferred a 40% reduction
in grey matter injury.
Conclusions: We have established a postnatal day 4 rat model of HI for the study of preterm brain injury. MgSO4
provides a marked preconditioning protection both in postnatal day 4 rats and in postnatal day 5 mice.
1. Introduction
Brain injury in preterm infants is a major clinical problem causing
mortality and neurological morbidity (Ferriero 2004; Hagberg et al.,
2015). The risk of neurodevelopmental impairment is inversely pro-
portional to gestational age at birth (Kurinczuk et al., 2010).
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Approximately 30% of infants born preterm (<28 weeks of gestation)
will suﬀer from CP, cognitive impairment or behavioral deﬁcits in-
cluding autism spectrum disorders and ADHD (Brown et al., 2009;
Marlow et al., 2005; Volpe 2009a). Therefore there is an imperative
need to develop innovative treatment and preventive strategies.
Preterm brain injury in the human infant (encephalopathy of pre-
maturity) includes both overt brain injury often combined with peri-
ventricular/intraventricular hemorrhage (PVH/IVH) preferentially in
white matter (sometimes described as periventricular leukomalacia,
PVL) and impairment of brain development aﬀecting both grey and
white matter as well as neuronal connectivity (Ball et al., 2015; Batalle
et al., 2017; Inder et al., 1999a; Kidokoro et al., 2014; Pierson et al.,
2007; Volpe 2009b). In the white matter, pre-myelinated oligoden-
drocytes (preOLs) are aﬀected (causing the inability of these cells to
diﬀerentiate into mature oligodendrocytes) leading to cerebral hypo-
myelination (Back and Miller 2014; Ferriero 2004). Due to the large
quantity of preOLs in the periventricular white matter between gesta-
tional weeks 24–32, the neonatal human brain is highly susceptible to
hypoxia-ischemia (HI) during this period of development. In rodents,
the amount of preOLs is at its peak between post-natal day (PND) 2 and
PND 5 (Back et al., 2001) and at PND 6/7 the majority of preOLs are
already diﬀerentiating into mature oligodendrocytes (OLs) allowing
early myelination to take place (Craig et al., 2003).
The etiology behind brain lesions in preterm infants is multifactorial
and partly unknown but most likely includes infection/inﬂammation,
hyperoxia, hypoxia, ischemia, excitotoxicity and injury secondary to
IVH/PVH (Favrais et al., 2011; Hagberg et al., 2002; Volpe 2009b). In
order to model HI in animals corresponding to the human at preterm,
the Rice-Vannucci model has been adapted to younger animals in-
cluding PND 5 (Albertsson et al., 2014), PND 6 (Shen et al., 2010) and
PND 7 mice as well as PND 3 rats (Sizonenko et al., 2003).
Antenatal magnesium sulphate (MgSO4) has been shown to exert
neuroprotective eﬀects and according to clinical cohort studies, the
oﬀspring to mothers treated with MgSO4 antenatally (administered for
prevention of preterm labor or as seizure prophylaxis in preeclampsia)
had a lower occurrence of both CP (Nelson and Grether 1995) and in-
traventricular/periventricular hemorrhage (Kuban et al., 1992). Ran-
domized controlled trials have subsequently conﬁrmed these results
and a recent meta-analysis demonstrated that the frequency of CP or
moderate/severe motor disability was reduced by ∼30% by antenatal
MgSO4 (Doyle et al., 2009). Furthermore, the rate of echolucent and
echodense brain lesions (Hirtz et al., 2015) as well as cerebellar he-
morrhages (Gano et al., 2016) has been shown to be attenuated by
antenatal MgSO4 treatment.
Preconditioning is the induction of tolerance by a sub-lethal ex-
posure to a subsequent severe insult (Meller and Simon 2013). A pre-
conditioning response can be obtained in the immature brain by a
variety of stimuli such as sub-threshold hypoxia (Gidday et al., 1994;
Gustavsson et al., 2005) or xenon pre-exposure (Shu et al., 2010) which
can reduce HI brain injury by>80%. Most experimental studies have
failed to conﬁrm that MgSO4 is neuroprotective if given immediately
prior to, during or after HI (de Haan et al., 1997; Galvin and Oorschot
1998; Greenwood et al., 2000) but MgSO4 administered to mothers in
preterm labor is actually given hours to days before the presumed most
critical period for development of brain injury. In a recent study
(Koning et al., 2017), we demonstrated that MgSO4 induces strong
preconditioning when administered as a bolus 6 days to 12 h prior to
the induction of HI in the PND 7 rat (which is developmentally similar
to that of a human near-term fetus) (Vannucci and Vannucci 1997). But
there is no information whether MgSO4 also induces preconditioning in
the more immature rodent brain better corresponding to extreme pre-
maturity.
The aim of the present study is ﬁrstly to describe a reproducible, HI
rat model (PND 4) of preterm brain injury more comparable to that seen
in the extremely preterm (<28 weeks of gestation) human infant.
Secondly, we will evaluate the preconditioning eﬀect of MgSO4 in the
PND 4 rat model as well as in a previously described PND 5 mouse
model (Albertsson et al., 2014) of preterm brain injury after HI.
2. Materials & methods
2.1. Experimental design
A power analysis was conducted prior to data acquisition in the
diﬀerent experiments contained in this study to make sure we would
obtain an appropriate sample size for a reliable comparison.
Throughout this study, pups were randomly allocated into diﬀerent
groups and numerically marked (as opposed to marked according to
treatment) in order to avoid bias. Pups from a variety of litters were
included in each experimental part to avoid litter speciﬁc outcomes and
promote diversity. Additionally, all experiments of this study were
conducted in replicates where the number and composition of re-
plicates was determined by litter size, date of birth and amount of
animals/samples possible to study at one time. Furthermore, all mea-
surements were conducted by blinded researchers, unaware of the key
to the numerical system by which the samples were marked. The data
was then un-blinded at the time of statistical analysis.
Here we have used male and female Wistar rat pups from in house
breeding at the facility of Experimental Biomedicine. Additionally, we
used male and female wild type mice of the C57Bl/6 strain, also from in
house breeding at Experimental Biomedicine. Animal experimental
procedures conformed to guidelines established by the Swedish Board
of Agriculture (SJVFS 2015: 38), were approved by the Gothenburg
Animal Ethics Committee (ethical license 01-2016) and are reported in
a manner consistent with the ARRIVE (Animal Research: Reporting in
vivo Experiments) guidelines. Animals were housed at the facility of
Experimental Biomedicine with access to food and water ad libitum.
The day of birth was deﬁned as PND 0. Mortality was low and not
diﬀerent between groups.
2.2. Hypoxia-Ischemia (HI)
At PND 4 (rats) or PND 5 (mice) pups were exposed to neonatal HI
as previously described (Rice et al., 1981; Vannucci and Vannucci
1997) and adjusted to newborn mouse (Albertsson et al., 2014). Pups
were anesthetized with 5% isoﬂurane (IsoFlo vet 100%; Abbott La-
boratories Ltd, Illinois, USA) for induction and 1.5% for maintenance
(< 5min), in 1:1 oxygen-nitrogen mixture. The left common carotid
artery was ligated with a 6.0 silk suture (Seide; Vömel, Germany) and
the incision was closed and inﬁltrated with a local anesthetic (Xylocain
20mg/ml, lidocain, hydrochloride; Astra Zeneca, Södertälje, Sweden).
Pups were allowed to recover with their dams for 1 h before they were
placed in a chamber with humidiﬁed air for 10min, followed by 60, 70
or 80min of hypoxia (8% oxygen in 92% nitrogen) for rats and 70min
for mice (10% oxygen in 90% nitrogen) and an additional 10 min in
humidiﬁed air (temp 36 °C). Seven days post HI the pups were deeply
anesthetized with 0.1ml of thiopental (Pentocur, Thiopental, 50mg/ml
intraperitoneally (i.p); Abcur AB, Helsingborg, Sweden) and sacriﬁced
for histological processing; brains were ﬁxed by transcardial perfusion
using 6% paraformaldehyde (Histoﬁx; Histolab, Gothenburg, Sweden).
2.3. MgSO4 administration
Pups of either sex were divided randomly into two groups and in-
jected intraperitoneally (i.p.) at PND 3 (rats) or PND 4 (mice) with a
single dose of MgSO4 (Magnesium, Addex; Fresenius Kabi, Halden,
Norway) (Koning et al., 2017) or as vehicle an equivalent volume of
saline (Saline 9mg/ml, B Braun Melsungen AG, Melsungen, Germany)
24 h prior to the induction of HI (Table 1). Pups were then returned to
their dams.
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2.4. Macroscopical brain injury scoring in rats
Once dissected out the rat brains were photographed and graded
macroscopically according to a previously published scoring system
(range: 0–4), (Bona et al., 1998) see Table 2.
2.5. Tissue preparation
After dehydration, rat and mouse brains were embedded in paraﬃn
and cut with a microtome (Meditome A550) into 7 μm thick sections at
approximately −3.3mm from bregma (level of hippocampus) as well
as at approximately 0.2 mm from bregma (level of striatum) for histo-
chemical staining as shown in Fig. 1.
2.6. Immunohistochemistry
Brain sections were prepared for immunohistochemical staining by
deparaﬃnation in xylene followed by graded alcohol rehydration and
boiling in 0.01M citric acid buﬀer (pH 6.0) for antigen recovery for
10min. Sections were treated with 3% H2O2 in phosphate-buﬀered
saline (PBS) for blocking of endogenous peroxidase followed by
blocking for nonspeciﬁc binding with appropriate serum. Sections were
then incubated with primary antibody: Mouse anti-MAP-2 (1:1000;
M4403 Sigma-Aldrich, St. Louis, Missouri, USA) or Mouse anti-MBP
(1:10 000; SMI-94 Covance, Princeton, New Jersey, USA) overnight
followed by washing and incubation in appropriate secondary antibody
and ABC Elite. For visualization of immunoreactivity, sections were
submerged into 0.5mg/ml 3.3-diaminobenzidine (DAB), NiSO4.
2.7. Thionin/Acid fuchsin
Histological analysis was undertaken using 7 μm sections at the le-
vels of hippocampus and striatum. Oven baked sections were depar-
aﬃnated in xylene and rehydrated in graded alcohol and distilled H2O.
For the assessment of gross morphological changes sections were
stained with Thionine/Acid Fuchsin.
2.8. Brain injury analysis
Grey matter injury was quantiﬁed as the area loss of microtubule-
associated protein-2 (MAP-2) immunoreactivity at the levels of anterior
hippocampus and striatum. The total area of MAP-2 positive staining in
each hemisphere was outlined and measured (MicroImage, version 4.0,
Olympus Optical) and the amount of tissue loss was calculated by
subtracting the MAP-2 positive area in the ipsilateral hemisphere from
the contralateral hemisphere.
Loss of myelin basic protein (MBP) was used im-
munohistochemically to determine white matter injury. The area of
MBP positive staining in the corpus callosum was outlined and mea-
sured (MicroImage, version 4.0, Olympus Optical) in both hemispheres
after which the proportion (%) of white matter injury was calculated by
comparing the ipsilateral hemisphere to the contralateral hemisphere.
Changes in gross morphology and neuronal death were assessed by
light microscopy of Thionine/Acid Fuchsin stained sections. The mac-
roscopical injury was evaluated in the lateral ventricles and the mi-
croscopical injury was evaluated in cerebral cortex, hippocampus,
striatum and thalamus.
2.9. Measurement of magnesium levels in serum
At PND 3 (rats) or PND 4 (mice) pups of either sex were injected i.p.
with a single dose of MgSO4 (rats: 1.1 mg/g, n=19; mice: 0.55mg/g
(n= 12), 0.74mg/g (n=12) or 0.92mg/g (n=12) or an equivalent
volume of saline as vehicle (rats: n= 20; mice: n= 14). Animals were
killed by decapitation after 3 or 24 h followed by immediate collection
of blood. The serum samples were then analyzed for Mg2+ concentra-
tion (Cobas 8000 Roche Diagnostics Scandinavia AB) by
Centrallaboratoriet Klinisk Kemi at the Sahlgrenska University Hospital,
Table 1
Summary of MgSO4 doses used throughout this study.
Species MgSO4 dose n
Rat 1.1mg/g 18
Rat Vehicle 18
Mouse 0.55mg/g 20
Mouse 0.74mg/g 14
Mouse 0.92mg/g 19
Mouse Vehicle 45
Table 2
Brain injury scoring protocol for gross morphology modiﬁed after (Bona et al., 1998).
Score Criteria
0 Normal
0.5 Almost completely normal, left hemisphere slightly smaller
1 Plaque on surface, minimal hypotrophy
1.5 Gradually more pronounced hypotrophy, with or without plaque
2 Obvious cavitation/loss of tissue
2.5 Cysts are added
3 Only midline left
3.5 Only frontal cortex left
4 Complete loss of left hemisphere
Fig. 1. Schematic representation of the coronal sections of the rat brain analyzed in the present study.
(A) Relevant anatomical structures at−3.3mm from bregma depicted in this schematic image including Hippocampus, Thalamus and CA3 region. (B) Anatomical structures analyzed in
sections at +0.2 from bregma including corpus callosum (CC), striatum, caudate putamen (CPU) and lateral ventricle (LV), (Adapted from the Rat Brain Atlas http://labs.gaidi.ca/rat-
brain-atlas/).
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Gothenburg, Sweden.
2.10. Statistical measurements
All statistical analysis was performed using Graph Pad Prism. The
statistical signiﬁcance was determined by unpaired two-tailed t-tests or
ANOVA with Tukey’s multiple comparisons test as described in the
ﬁgure legends (Mean ± SEM). P values< 0.05 where considered sta-
tistically signiﬁcant.
Fig. 2. Evaluation of hypoxia duration in a PND 4 rat model of HI.
Brain injury evaluated 7 days post HI with (A) neuropathological scoring and immunoreactivity for MAP-2 (tissue area loss as % of contralateral) at the level of (B) hippocampus and (C)
striatum and immunoreactivity for MBP (tissue area loss as % of contralateral) at the level of (D) hippocampus and (E) striatum. Representative coronal brain sections (F) stained with
MAP-2 (a, b, c) and MBP (d, e, f) from a hypoxia duration of 60min (a, d), 70min (b, e) and 80min (c, f) at the hippocampal level. One way ANOVA with Tukey’s multiple comparisons
test *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
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Fig. 3. Brain injury evaluated after 60, 70 or 80min of HI in rats.
A–F. Representative thionin/acid fuchsin-stained sections of contralateral (A) and ipsilateral (B) hemisphere, 7 days after exposure to 60 (A & B), 70 (C & D) or 80min (E & F) of HI (40×
magniﬁcation). G–L. Representative images of thionin/acid fuchsin-stained sections in ipsi- and contralateral hemisphere of the hippocampal C3 layer after 60 (G & H), 70 (I & J) and
80min (K & L), 400× magniﬁcation. Neuronal loss in this layer is indicated by arrows. M–R. Tissue area (mm2) in hippocampus of contralateral and ipsilateral hemisphere in grey and
white matter 7 days after 60 (NS) (M & N), 70 (O & P) and 80min (Q & R) of HI (n= 22/group), Mean ± SEM, Students unpaired t-test. S–Y. Tissue area (mm2) in striatum of
contralateral and ipsilateral hemisphere in grey and white matter 7 days after 60 (S & T), 70 (U & V) and 80min (X & Y) of HI (n= 22/group). Length indicator corresponds to 1000 um.
Mean ± SEM, Students unpaired t-test *p < 0.05; **p < 0.01; ****p < 0.0001.
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3. Results
3.1. Brain injury in white and grey matter in the PND 4 rat after HI
In order to determine the duration of hypoxia needed to produce a
focal brain injury in both white and grey matter in the PND 4 rat we
evaluated the injury obtained from left carotid artery ligation according
to the Rice-Vannucci model followed by 60, 70 and 80min of hypoxia.
Macroscopic scoring (Table 2, Fig. 2A) of brain injury showed that
60min of hypoxia resulted in an injury in 50% of the animals though
this injury was minor, consisting only of a slightly smaller ipsilateral
hemisphere.
These results were subsequently conﬁrmed by im-
munohistochemical staining for MAP-2 (Fig. 2B, 2C, 2F) and MBP
(Fig. 2D–F) concluding that grey- (Fig. 3M) and white- (Fig. 3N) matter
injury in the ipsilateral hemisphere was not signiﬁcantly diﬀerent after
Fig. 4. Brain injury evaluation after MgSO4 or vehicle pre-treatment and exposure to 80min of HI in rats.
A–C. Brain injury evaluation with macroscopical scoring (A), and histochemical staining for MAP-2 (B) and MBP (C) 7 days post 80min of HI in vehicle or MgSO4 PC rat pups measured as
tissue area loss (% of contralateral) at the level of hippocampus and striatum. D–E & F–G. Representative thionin/acid fuchsin-stained sections of hippocampus in the contralateral (D) and
ipsilateral (E) hemisphere, 7 days after exposure to 80min of HI in vehicle (D & E) or MgSO4 (H & I) pre-treated pups, (4× magniﬁcation). F–G & J–K. Pyramidal layer in the C3 region of
hippocampus in the contralateral (F & G) and ipsilateral (K & J) hemisphere, (40× magniﬁcations). Neuronal loss indicated by arrows and vacuolation indicated by arrowhead.
Length indicator corresponds to 1000 μm. Mean ± SEM, Students unpaired t-test *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
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60min of hypoxia compared to the contralateral hemisphere at the
level of hippocampus although a signiﬁcant diﬀerence could be seen at
the level of striatum in both grey- (Fig. 3S) (p < 0.01) and white-
matter (Fig. 3T) (p < 0.02). Thionin/Acid Fuchsin staining revealed
that after 60min of hypoxia only 3/22 animals presented a hemisphere
infarction in the cerebral hemisphere ipsilateral to the carotid artery
ligation. The injury evaluation of cerebral cortex, hippocampus,
striatum and thalamus showed very few and small isolated infarcts or
groups of necrotic cells in the cerebral cortex (Fig. 3B, H), combined
with mild or no atrophy at the level of hippocampus (Fig. 3B). The
pyramidal layer of neurons in the C3 region of hippocampus was intact
with minor neuronal loss (Fig. 3H). No injury was detected in the
contralateral hemisphere after HI (Fig. 3A, G).
After 70min of hypoxia, a higher percentage of animals (17/20)
obtained a macroscopically visible brain injury (Fig. 2A) although the
severity of the injury was inconsistent within the group and the pups
showed only mild regional white matter injury (Fig. 2A, B, F) in the
ipsilateral hemisphere as compared to the contralateral hemisphere
(Fig. 2P) (p < 0.05). Grey matter injury (Fig. 2A, 2B) could be detected
in the cerebral cortex and hippocampus (Fig. 3D, 3J) of the ipsilateral
hemisphere, characterized mainly by slight tissue area reduction in grey
(Fig. 3O) (p < 0.03) and white matter (Fig. 3P) (p < 0.02) at the
hippocampal level as well as at the level of striatum (Fig. 3U & V)
(p < 0.01 and p < 0.04 respectively). A hemisphere infarction was
detected in 3/20 brains. The ipsilateral hemisphere presented occa-
sionally with small groups of necrotic cells detected in cerebral cortex,
and degenerating neurons could be found in the hippocampal layer
which also showed mild atrophy (Fig. 3D). When examining the C3
region of hippocampus we found moderate neuronal loss in the pyr-
amidal layer and slight structural disruption (Fig. 3J). No such injury
was detected in the contralateral hemisphere after HI (Fig. 3C, I).
80min of hypoxia resulted in a consistent macroscopically detect-
able brain injury (Fig. 2) characterized by hippocampal atrophy and
cortical infarction (Fig. 3F) in the ipsilateral hemisphere. All animals in
this group obtained a macroscopically visible brain injury (Fig. 2A) and
subsequent immunohistochemical staining with MAP-2 (Fig. 2B) and
MBP (Fig. 2B) revealed extensive hippocampal and cortical injury. A
signiﬁcant reduction in both grey (Fig. 3Q) (p < 0.0001) and white
matter (Fig. 3R) (p < 0.0001) was detected in the ipsilateral hemi-
sphere compared to the contralateral hemisphere at the level of hip-
pocampus. An equally severe injury was detected in grey (Fig. 3X)
(p < 0.0001) and white matter (Fig. 3Y) (p < 0.0001) at the level of
striatum.
After 80min of hypoxia, 17/22 animals presented a hemisphere
infarction (Fig. 3F) in combination with asymmetric lateral ventricles
with moderate or extensive dilation in the ipsilateral hemisphere
(Fig. 3F). The insult resulted in a moderate or extensive conﬂuent in-
farct in the cerebral cortex accompanied by cell necrosis and infarction
at the level of hippocampus (Fig. 3F). Extensive neuronal loss was de-
tected in all animals in the pyramidal layer at C3 in the ipsilateral
hemisphere after 80min of hypoxia (Fig. 3L). No such injury was de-
tected in the contralateral hemisphere after HI. Therefore 80min of
hypoxia was used for the remaining experiments in PND 4 rats.
3.2. Evaluation of brain injury in the PND 4 rat after MgSO4 administration
Next, we sought to explore whether MgSO4 induces tolerance
(preconditioning) in the preterm brain using our validated rat model of
preterm brain injury. The macroscopic scoring of rat pups pretreated
with MgSO4 or saline as vehicle at PND 3, 24 h prior to the induction of
80min of HI, showed that there is a signiﬁcant reduction of brain in-
jury, from 2.0 ± 0.3, n=18 in the vehicle group to 0.9 ± 0.3, n=18
in the MgSO4 group (p=0.0017) (Fig. 4A).
For assessment of grey matter loss we measured the loss of im-
munoreactivity for MAP-2 in the ipsilateral brain hemisphere compared
to the contralateral hemisphere, and found a signiﬁcant brain injury
reduction of ∼74% in the MgSO4 pre-treated group at the level of
hippocampus (p=0.002) and∼58% reduction at the level of striatum
(p≤ 0.01), compared to vehicle (Fig. 4B).
Next, we assessed the eﬀect of MgSO4 treatment on the loss of white
matter by measuring myelin basic protein (MBP) immunoreactivity. We
found a signiﬁcant diﬀerence between rats pre-treated with MgSO4 vs
vehicle with an injury reduction of∼67% in the MgSO4 preconditioned
group in hippocampus (p=0012) and ∼52% in striatum (p= 0.02)
(Fig. 4C).
Using Thionine Acid/Fuchsin the extent of brain injury was scored
both macroscopically and microscopically in paraﬃn sections. The
brain injury in saline treated animals was characterized by macro-
scopically visible injury containing plaques and/or cysts in the ipsi-
lateral hemisphere. The regional microscopic evaluation demonstrated
that the majority of animals in this group suﬀered from infarction
combined with moderate/extensive atrophy of cortex and hippocampus
accompanied by cell necrosis in these areas combined with asymme-
trical lateral ventricles dilated in the ipsilateral hemisphere (Fig. 4B). In
the MgSO4 pre-treated group the macroscopically visible injury was less
extensive and neuronal loss was limited (Fig. 4I). Furthermore, only a
small proportion (2/20) of the brains exhibited an infarct after MgSO4
preconditioning as compared to (10/17) in the saline treated group.
The amount of necrotic cells was reduced overall in the MgSO4 pre-
conditioned group (Fig. 4F) and the pyramidal layer at C3 did not
present the same extent of neuronal loss (degenerating neurons) as in
the vehicle group (Fig. 4D vs. 4H).
Using immunoreactivity for MAP-2 and MBP, the total tissue area in
grey and white matter was compared in the ipsilateral vs contralateral
hemispheres of hippocampus in both the vehicle (saline) and the MgSO4
preconditioned group (Fig. 5A–D) after 80min of HI. While a large
reduction in tissue area of both grey and white matter was detected in
the ipsilateral hemisphere in the vehicle group compared with the
contralateral hemisphere (p < 0.05), no signiﬁcant grey or white
matter tissue reduction in the ipsilateral hemisphere vs the con-
tralateral hemisphere was detected in the MgSO4 pre-treated group.
Analysis of grey matter tissue reduction at the level of striatum in the
vehicle and the MgSO4 pre-treated group revealed a large loss of tissue
in the vehicle group (p < 0.0001) and a smaller but yet signiﬁcant
tissue loss in the MgSO4 group (Fig. 5C) (p < 0.02). A signiﬁcant tissue
reduction was detected also in white matter in the ipsilateral hemi-
sphere compared to the contralateral hemisphere at the level of
striatum in the vehicle group (p < 0.0002) whereas no signiﬁcant
tissue reduction was seen in the MgSO4 pre-treated group (Fig. 5D).
3.3. Eﬀect of MgSO4 on brain injury in the PND 5 mouse after HI
The eﬀect of pre-treatment with MgSO4 was also analyzed in a PND
5 mouse model of preterm brain injury. MgSO4 was given 24 h prior to
HI induced at PND 5 in mice using a newly characterized model of
preterm brain injury (Albertsson et al., 2014). We found that a dose of
0.92mg/g MgSO4 provided a signiﬁcant reduction of grey matter injury
(40%) compared to vehicle (Fig. 6A–C) also in this PND 5 mouse model,
whereas the two lower MgSO4 doses (0.55mg/g and 0.74mg/g) (data
not shown) did not provide any signiﬁcant neuroprotection.
3.4. The magnesium levels in serum after MgSO4 pre-treatment
The level of Mg2+ was measured in serum samples from rat pups
preconditioned with 1.1mg/g MgSO4 or saline as vehicle at 3 or 24 h
prior to blood collection. In PND 4 rats, serum Mg2+ levels increase
transiently (peaking at 3 h after administration) reaching
4.1 ± 0.2mmol/l after injection with 1.1mg/g MgSO4, and the Mg2+
levels were completely normalized at 24 h after injection (Fig. 6D). In
the PND 5 mice, the neuroprotective dose of 0.92mg/g MgSO4 reached
a serum Mg2+ concentration of 2.7 ± 0.3mmol/l at 3 h after admin-
istration though the amount of Mg2+ was nearly but not completely
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normalized at 24 h (Fig. 6E) as in the PND 4 rat (p < 0.05).
4. Discussion
Here we have established a reproducible model of HI injury in the
PND 4 rat for the study of perinatal brain injury in the very immature
brain. Using this PND 4 rat model as well as an HI model in PND 5 mice,
we found that MgSO4 induces preconditioning neuroprotection in
agreement with our previous ﬁndings in the PND 7 HI model in rats and
ibotenate model in mice (Koning et al., 2017).
Comparing neural maturation between species is not simple but the
developmental age of the PND 7 rat brain is generally considered to
reﬂect that of a human fetus or newborn at 32–34 gestational weeks
(GW) (Vannucci and Vannucci 1997) with complete cerebral cortical
neuronal layering, little myelination of the white matter and involution
of the germinal matrix (Towﬁghi et al., 1995). At the time of birth the
neurogenesis of the rat brain is largely complete meaning that it de-
velopmentally corresponds to approximately 20 GW in the human
(Clancy et al., 2001; Dobbing and Sands 1979). In order to mimic a
more immature brain injury, corresponding to that of a ∼28 GW
human fetus, we chose the PND 4 rat based on the white matter (Back
et al., 2001) and cortical developmental stages (Honig et al., 1996).
After the duration of 70min of hypoxia, 85% of the rat pups ob-
tained a macroscopically visible injury extending through both white
and grey matter, characterized by mild atrophy and very limited neu-
ronal loss in hippocampus accompanied by small groups of degen-
erating neurons in the cerebral cortex. A mild infarct in cortex or hip-
pocampus was seen in ∼13% of the animals. HI for 80min induced
injury in all rat pups, largely restricted to the cerebral hemisphere ip-
silateral to the carotid artery ligation. The injury was characterized by
moderate hippocampal atrophy and subcortical/periventricular white
matter damage in cerebral cortex which is diﬀerent from that seen after
injury at PND 7. The higher proportion of white matter injury also
better corresponds to brain injury in preterm infants (Inder et al.,
1999b; Pierson et al., 2007). In 2003 Sizonenko et al. adapted the Rice-
Vannucci model to PND 3 rats aiming to mimic the injury of a human
fetus at 25–28 GW. The setup of our model diﬀers slightly from that
used by Sizonenko et al. partially because they place the pups in
85–90% humidity for 30min after ligation, directly followed by 30min
6% hypoxia whereas we allow the pups 1 h rest with the dam followed
Fig. 5. Evaluation of grey and white matter tissue area reduction after MgSO4 pre-treatment in PND 4 rats.
Total tissue area (mm2) at the levels of hippocampus and striatum between contralateral and ipsilateral hemisphere in grey (A & C) and white (B & D) matter, 7 days after 80min of HI in
vehicle (n=19) and MgSO4 (n= 19) pre-treated animals, Mean ± SEM, Students unpaired t-test, *p < 0.05; ***p < 0.001; ****p < 0.0001.
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by 80min 8% hypoxia. Additionally, they detect a diﬀerence for the
ipsi- and contralateral hemispheres after HI compared to control only in
the parietal cortex (Sizonenko et al., 2003). Hence there is no sig-
niﬁcant diﬀerence between the ipsi- and contralateral hemispheres in
the thalamus, hippocampus or striatum after HI in their model whereas
we detect signiﬁcant brain injury in cortex as well as in hippocampus
and striatum in our model.
MgSO4 (1.1 mg/g) preconditioning has neuroprotective properties
with a brain injury reduction of ∼74% in grey matter and ∼64% in
white matter at the level of hippocampus in this PND 4 rat model of HI
which is comparable to the injury reduction seen by MgSO4 given 24 h
prior to HI in the PND 7 rat (∼63% in grey matter and∼89% in white
matter, Koning et al., 2017). Preconditioning with MgSO4 reduced the
amount of cellular necrosis and protected the C3 hippocampal layer
from extensive neuronal loss. Additionally, the cerebral cortex was
largely protected against the vast tissue and neuronal loss seen in the
control group.
We also found that the MgSO4 neuroprotection seen in this PND 4
rat model can be obtained in a PND 5 mouse model of perinatal brain
injury. Additionally, the serum Mg2+ concentrations measured in both
models 3 h post injection were within the therapeutic window
(2–4mmol/L) when MgSO4 is given antenatally to women for seizure
prophylaxis in preeclampsia or for neuroprotection. Taken together
with our recently published data (Koning et al., 2017), we have now
demonstrated that MgSO4 provides preconditioning neuroprotection in
four brain injury models (HI at PND 4 rat, PND 7 rat and PND 5 mouse
as well as mouse PND 5 ibotenate lesion), supporting that this phe-
nomenon is generalizable to some extent irrespective of species, type of
insult and developmental age.
The present results together with our previous report oﬀers some
mechanistic insights into how MgSO4 protects the immature brain, i.e.
it has to be given as a pre-exposure at least ≥12 h prior to the insult
(Koning et al., 2017) whereas MgSO4 is often not eﬀective if given just
prior, during or after the insult (de Haan et al., 1997, Galvin and
Oorschot 1998, Greenwood et al., 2000; Koning et al., 2017). We be-
lieve that MgSO4 oﬀers preconditioning, i.e. it reduces the vulnerability
of the immature brain similar to subthreshold hypoxia (Gidday et al.,
1994; Gustavsson et al., 2005; Meller and Simon 2013), glucocorticoids
(Barks et al., 1991) or xenon (Gustavsson et al., 2005; Shu et al., 2010).
Such an interpretation is supported by the fact that the serum magne-
sium concentrations are normalized (or nearly normalized) at the time
of the severe insult and still brain injury is decreased dramatically.
MgSO4 changes the expression of a number of genes which in turn alters
the mitochondrial and metabolic state of the immature CNS which
renders it more resistant to a subsequent severe insult (Koning et al.,
2017). However, this genomic/metabolic transformation into a more
Fig. 6. Brain injury evaluation after MgSO4 or ve-
hicle pre-treatment and exposure to 70min of HI in
PND 5 mice and serum Mg2+ concentration.
A. Brain injury measured as ipsilateral tissue area
loss (% of contralateral) in grey matter by im-
munoreactivity for MAP-2 at the level of hippo-
campus in PND 5 mice after pre-exposure to MgSO4
(0.92mg/g) or an equivalent volume of saline as
vehicle. (Mean ± SEM, Students unpaired t-test,
p < 0.05). B–C. Representative brain sections from
mice pre- treated with vehicle (B) or MgSO4 (C) at
the level of hippocampus with MAP-2 staining. D.
Serum Mg2+ concentration measured in PND 4 rat
samples collected at 3 or 24 h after i.p. injection with
MgSO4 (1.1 mg/g) (n=9) or vehicle (n= 9). E.
Serum Mg2+ concentration measured in PND 5 mice
samples collected at 3 or 24 h after i.p. injection with
MgSO4 (0.92mg/g) (n= 7) or vehicle (n=6),
Mean ± SEM, Students unpaired t-test, **p < 0.01;
***p < 0.001; ****p < 0.0001.
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resistant state develops over time and is not complete until 12–24 h
although it seems to last for over 6 days, at least in the PND 7 rat model.
Clinically, it is of importance that this preconditioning neuropro-
tection induced by a MgSO4 bolus has now also been shown in two
preterm models of HI. There is a need for development of preventive
approaches and the data presented in this study support previous
clinical ﬁndings demonstrating that MgSO4 is an eﬀective neuropro-
phylaxis when administered antenatally. That is, treatment must start
some time before the actual critical period for insults to the brain
during delivery and the ﬁrst few days of life. The possibility of oﬀering
only a MgSO4 bolus rather than also giving infusions of MgSO4 during
delivery up until the time of birth reduces the need for extensive
monitoring of the mother and could also possibly decrease the risk of
necrotizing colitis, gut perforations and perinatal mortality (Borja-Del-
Rosario et al., 2014; Kamyar et al., 2016; Rattray et al., 2014). Indeed,
in one of the randomized controlled studies (Marret et al., 2007) only a
bolus of 4 g MgSO4 was given. The long-term eﬀects were promising
(Chollat et al., 2014) but, unfortunately, the study was underpowered.
We further believe that 6 g (rather than 4 g) of MgSO4 is needed to
reach a transient peak of magnesium in serum of 2.5–4mmol/l which is
required to achieve optimal brain protection, at least judged from our
experimental studies. Clinical studies are warranted to examine if a 6 g
MgSO4 bolus is an eﬀective mode of neuroprophylaxis with greater
safety and compliance for women in preterm labor.
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